{"id":"W4367299362","doi":"10.57264/cer-2023-0009","title":"Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant","year":2023,"lang":"en","type":"letter","venue":"Journal of Comparative Effectiveness Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Palbociclib; Medicine; Fulvestrant; Oncology; Breast cancer; Quality of life (healthcare); Internal medicine; Cancer; Gynecology; Metastatic breast cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003121046,0.0004463019,0.003315134,0.001945445,0.00007150761,0.0000281827,0.0002935132,0.0002715703,0.00001202193],"category_scores_gemma":[0.0002617232,0.0003188954,0.0001163944,0.00176992,0.0008432685,0.0004206462,0.0000863298,0.003734494,7.269762e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007152284,"about_ca_system_score_gemma":0.0008096162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004220865,"about_ca_topic_score_gemma":0.0002873242,"domain_scores_codex":[0.9917998,0.003293835,0.001523978,0.0005220912,0.00227577,0.0005845483],"domain_scores_gemma":[0.989943,0.005628314,0.001731379,0.0003344665,0.002225865,0.0001369971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02042253,0.00048115,0.9652222,0.003232631,0.0007251785,0.00007249375,0.002387261,0.0007311589,0.0007581877,0.000003857243,0.0005133119,0.005450041],"study_design_scores_gemma":[0.01392894,0.003087535,0.9633977,0.01556722,0.00007486981,0.000009885292,0.0003456222,0.00002274387,0.002806656,0.0001348894,0.0003356549,0.0002882552],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816983,0.0009975946,0.0001842639,0.01518036,0.00009048636,0.001711662,0.0001081324,0.00001064425,0.00001861251],"genre_scores_gemma":[0.9980419,0.0000827792,0.000268589,0.001025979,0.0003017936,0.0001307754,0.00005230357,0.00008326011,0.00001267073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0163436,"threshold_uncertainty_score":0.9999263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1251605424464233,"score_gpt":0.4609705745515502,"score_spread":0.3358100321051269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}